first-exposur adapt resist antibiot vivo mean optim clinic use first exposur gram-neg bacilli aminoglycosid antibiot vitro induc biphas bactericid respons adapt drug resist daiko jackson lolan livermor infect di jackson daiko lolan infect di therapeut implic netilmicin treatment pseudomona aeruginosa infect normal neutropen mice first dose bactericid rate rapid cfu/h dose mg/kg twofold increas dosag number bacteria second-phas bactericid rate slow equal cfu/h dose multiple-dos regimen amount netilmicin dose effect dose dose drug level plasma mic effect regimen first exposur high drug concentr adapt resist dose start treatment temporari surviv bacterem neutropen mice second dose interv thigh infect neutropen mice first bactericid effect 